Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Combi-elastography is a B-mode ultrasound-based method in which two elastography modalities are utilized simultaneously to assess metabolic dysfunction-associated steatotic liver disease (MASLD). However, the performance of combi-elastography for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and determining fibrosis severity is unclear. This study compared the diagnostic performances of combi-elastography and vibrationcontrolled transient elastography (VCTE) for identifying hepatic steatosis, fibrosis, and high-risk MASH. Methods: Participants who underwent combi-elastography, VCTE, and liver biopsy were selected from a prospective cohort of patients with clinically suspected MASLD. Combi-elastographyrelated parameters were acquired, and their performances were evaluated using area under the receiver-operating characteristic curve (AUROC) analysis. Results: A total of 212 participants were included. The diagnostic performance for hepatic steatosis of the attenuation coefficient adjusted by covariates from combi-elastography was comparable to that of the controlled attenuation parameter measured by VCTE (AUROC, 0.85 vs 0.85; p=0.925). The performance of the combi-elastography-derived fibrosis index adjusted by covariates for diagnosing significant fibrosis was comparable to that of liver stiffness measured by VCTE (AUROC, 0.77 vs 0.80; p=0.573). The activity index from combi-elastography adjusted by covariates was equivalent to the FibroScan-aspartate aminotransferase score in diagnosing high-risk MASH among participants with MASLD (AUROC, 0.72 vs 0.74; p=0.792). Conclusions: The performance of combi-elastography is similar to that of VCTE when evaluating histology of MASLD.
Abstract
Background/Aims: Combi-elastography is a B-mode ultrasound-based method in which two elastography modalities are utilized simultaneously to assess metabolic dysfunction-associated steatotic liver disease (MASLD). However, the performance of combi-elastography for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and determining fibrosis severity is unclear. This study compared the diagnostic performances of combi-elastography and vibrationcontrolled transient elastography (VCTE) for identifying hepatic steatosis, fibrosis, and high-risk MASH. Methods: Participants who underwent combi-elastography, VCTE, and liver biopsy were selected from a prospective cohort of patients with clinically suspected MASLD. Combi-elastographyrelated parameters were acquired, and their performances were evaluated using area under the receiver-operating characteristic curve (AUROC) analysis. Results: A total of 212 participants were included. The diagnostic performance for hepatic steatosis of the attenuation coefficient adjusted by covariates from combi-elastography was comparable to that of the controlled attenuation parameter measured by VCTE (AUROC, 0.85 vs 0.85; p=0.925). The performance of the combi-elastography-derived fibrosis index adjusted by covariates for diagnosing significant fibrosis was comparable to that of liver stiffness measured by VCTE (AUROC, 0.77 vs 0.80; p=0.573). The activity index from combi-elastography adjusted by covariates was equivalent to the FibroScan-aspartate aminotransferase score in diagnosing high-risk MASH among participants with MASLD (AUROC, 0.72 vs 0.74; p=0.792). Conclusions: The performance of combi-elastography is similar to that of VCTE when evaluating histology of MASLD.
참고문헌 (42)
- Vuppalanchi R, "Therapeutic pipeline in nonalcoholic steatohepatitis", Nat Rev Gastroenterol Hepatol, 18, pp.373~392 (2021)
- Rinella ME, "A multisociety Delphi consensus statement on new fatty liver disease nomenclature", Hepatology, 78, pp.1966~1986 (2023)
- Kim GA, "Critical appraisal of metabolic dysfunction-associated steatotic liver disease : implication of Janus-faced modernity", Clin Mol Hepatol, 29, pp.831~843 (2023)
- Iwaki M, "Prognosis of biopsyconfirmed metabolic dysfunction-associated steatotic liver disease : a sub-analysis of the CLIONE study", Clin Mol Hepatol, 30, pp.225~234 (2024)
- Yoon EL, "Waiting for the changes after the adoption of steatotic liaver disease", Clin Mol Hepatol, 29, pp.844~850 (2023)
- Ferraioli G, "WFUMB guidelines and recommendations for clinical use of ultrasound elastography. Part 3 : liver", Ultrasound Med Biol, 41, pp.1161~1179 (2015)
- Bamber J, "EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1 : basic principles and technology", Ultraschall Med, 34, pp.169~184 (2013)
- Mikolasevic I, "Transient elastography(FibroScan(®))with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease : where do we stand?", World J Gastroenterol, 22, pp.7236~7251 (2016)
- Tamaki N, "Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method", Hepatol Res, 48, pp.821~828 (2018)
- Tomeno W, "Evaluation of the liver fibrosis index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases", Hepatol Res, 43, pp.735~742 (2013)
- Wong GL, "Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases", Clin Gastroenterol Hepatol, 6, pp.1027~1035 (2008)
- Friedrich-Rust M, "Liver fibrosis in viral hepatitis : noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography", Radiology, 252, pp.595~604 (2009)
- Yada N, "A newly developed shear wave elastography modality : with a unique reliability index", Oncology, 89(Suppl 2), pp.53~59 (2015)
- Friedrich-Rust M, "Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis", AJR Am J Roentgenol, 188, pp.758~764 (2007)
- Koizumi Y, "Liver fibrosis in patients with chronic hepatitis C : noninvasive diagnosis by means of real-time tissue elastography. Establishment of the method for measurement", Radiology, 258, pp.610~617 (2011)
- Sakamoto T, "Combinational elastography", Int Heart J, 63, pp.271~277 (2022)
- Yada N, "Influence of liver inflammation on liver stiffness measurement in patients with autoimmune hepatitis evaluation by combinational elastography", Oncology, 92(Suppl 1), pp.10~15 (2017)
- Yada N, "Non-invasive diagnosis of liver clinical condition by real-time tissue elastography and shear wave measurement : get more accessible by one probe", Medix, 63, pp.13~17 (2015)
- Yada N, "Diagnosis of fibrosis and activity by a combined use of strain and shear wave imaging in patients with liver disease", Dig Dis, 35, pp.515~520 (2017)
- Lee DH, "A sequential approach using the age-adjusted fibrosis-4 index and vibration-controlled transient elastography to detect advanced fibrosis in Korean patients with non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 55, pp.994~1007 (2022)
- European Association for the Study of the Liver(EASL), "EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease(MASLD)", J Hepatol, 81, pp.492~542 (2024)
- American Diabetes Association Professional Practice Committee, "2. Classification and diagnosis of diabetes : standards of medical care in diabetes : 2022", Diabetes Care, 45(Suppl 1), pp.S17~S38 (2022)
- Matthews DR, "Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
- Schiano TD, "Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C", Clin Gastroenterol Hepatol, 3, pp.930~935 (2005)
- Brunt EM, "Nonalcoholic fatty liver disease(NAFLD)activity score and the histopathologic diagnosis in NAFLD : distinct clinicopathologic meanings", Hepatology, 53, pp.810~820 (2011)
- Barr RG, "Elastography assessment of liver fibrosis : Society of Radiologists in Ultrasound consensus conference statement", Radiology, 276, pp.845~861 (2015)
- Cassinotto C, "Liver stiffness in nonalcoholic fatty liver disease : a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy", Hepatology, 63, pp.1817~1827 (2016)
- Sterling RK, "Development of a simple noninvasive index to predict significant fibrosis in patients with HIV", HCV coinfection, 2006, pp.43, 1317~1325
- Angulo P, "The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD", Hepatology, 45, pp.846~854 (2007)
- Wai CT, "A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C", Hepatology, 38, pp.518~526 (2003)
- Newsome PN, "FibroScan-AST(FAST)score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis : a prospective derivation and global validation study", Lancet Gastroenterol Hepatol, 5, pp.362~373 (2020)
- Fujimoto K, "Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C", Oncology, 84(Suppl 1), pp.3~12 (2013)
- Kobayashi K, "Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis : a meta-analysis", Eur Radiol, 25, pp.230~238 (2015)
- Colombo S, "Head-tohead comparison of transient elastography(TE), real-time tissue elastography(RTE), and acoustic radiation force impulse(ARFI)imaging in the diagnosis of liver fibrosis", J Gastroenterol, 47, pp.461~469 (2012)
- Koizumi Y, "New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode", PLoS One, 14, pp.e0221548~ (2019)
- Poynard T, "Liver fibrosis evaluation using real-time shear wave elastography : applicability and diagnostic performance using methods without a gold standard", J Hepatol, 58, pp.928~935 (2013)
- Zhao Y, "Preoperative combi-elastography for the prediction of early recurrence after curative resection of hepatocellular carcinoma", Clin Imaging, 79, pp.173~178 (2021)
- Fang C, "Ultrasound-based liver elastography : current results and future perspectives", Abdom Radiol(NY), 45, pp.3463~3472 (2020)
- Joo SK, "Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease", Liver Int, 38, pp.331~341 (2018)
- Castéra L, "Pitfalls of liver stiffness measurement : a 5-year prospective study of 13, 369 examinations", Hepatology, 51, pp.828~835 (2010)
- Chimoriya R, "The use of two-dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in nonalcoholic fatty liver disease", J Clin Med, 10, pp.95~ (2020)
- Guo HY, "Two-dimensional shear wave elastography utilized in patients with ascites : a more reliable method than transient elastography for noninvasively detecting the liver stiffness-an original study with 170 patients", Ann Transl Med, 11, pp.80~ (2023)